Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
7%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
21%
ALSO IN CANC
CANC
52
HOLDINGS
9%
ALSO IN BBH
SECTOR DRIFT (BBH minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 17.1% | 2.4% | 2.4% |
|
BEIGENE LTD. SPONSORED ADR | 3.0% | 1.7% | 1.7% |
|
GILEAD SCIENCES INC | 17.2% | 1.2% | 1.2% |
|
REGENERON PHARMACEUTICALS | 7.6% | 1.0% | 1.0% |
|
NATERA INC | 3.6% | 0.6% | 0.6% |
BBH Overweight Relative to CANC
|
GILEAD SCIENCES INC | 16.1% |
|
AMGEN INC | 14.7% |
|
VERTEX PHARMACEUTICALS INC | 9.6% |
|
REGENERON PHARMACEUTICALS | 6.6% |
 |
ARGENX SE ADR | 4.0% |
|
ALNYLAM PHARMACEUTICALS INC | 3.5% |
|
IQVIA HOLDINGS INC | 3.4% |
|
INSMED INC | 3.4% |
|
UNITED THERAPEUTICS CORP | 3.3% |
|
BIOGEN IDEC INC | 3.3% |
BBH Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.9% |
 |
NOVARTIS AG | -4.5% |
 |
ASTRAZENECA PLC | -4.4% |
|
ELI LILLY & CO | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.0% |
|
BRIDGEBIO PHARMA, INC. | -3.9% |
|
ARCELLX, INC. | -3.6% |
|
BRISTOL-MYERS SQUIBB CO | -3.6% |
|
MERCK & CO. INC. | -3.5% |
|
IMMUNOME, INC. | -3.2% |